By continuing to use the site you agree to our Privacy & Cookies policy

Hep C drug clears next hurdle towards NICE approval

A treatment for people with chronic hepatitis C has been given draft approval for use in the NHS, after the drug’s manufacturer agreed to reduce the price.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo